Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure
Clinical trial NCT03437226 · UNKNOWN
Trial details
- NCT number
- NCT03437226
- Sponsor
- Dr. Gerhard Pölzl
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-08
- Primary completion
- 2019-04-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.